The study is not without flaws, but it raises some concerns about the long term health-effects of antipsychotic augmentation.

Should you stop the old antipsychotic and start the new? Or gradually cross-taper them? This new meta-analysis compared three titration strategies to find the best way to switch from one antipsychotic to another in schizophrenia.

Generic metformin is being recalled by the batches, but is any of it still safe to prescribe?

When we choose medications, we typically think that we are paying attention to risks and benefits. But what happens when we just look through the lens of side effects? An entirely different picture emerges of what medications might be the better picks. You will be surprised and intrigued by this review of a very helpful study that will probably change your prescribing patterns.

There are many mood stabilizers to choose from, but which ones are the best tolerated? This meta-analysis looks at how they stack up in terms of weight gain, sedation, and overall discontinuation.

Delusional disorder may be in the psychotic chapter, but it doesn’t respond to antipsychotics like we’d expect. Joseph Pierre reviews how to use them, which ones to avoid, and how to enhance your therapeutic relationship with this population.

An atypical antipsychotic with a novel mechanism shows promise in bipolar depression.